Thu, August 20, 2020

Michelle Gilson Maintained (BMRN) at Strong Buy with Decreased Target to $95 on, Aug 20th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-95-on-aug-20th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Michelle Gilson of Canaccord Genuity, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Decreased Target from $119 to $95 on, Aug 20th, 2020.

Michelle has made no other calls on BMRN in the last 4 months.



There are 4 other peers that have a rating on BMRN. Out of the 4 peers that are also analyzing BMRN, 3 agree with Michelle's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Paul Matteis of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $100 on, Wednesday, August 19th, 2020
  • George Farmer of "BMO Capital" Maintained at Hold with Increased Target to $108 on, Thursday, August 6th, 2020
  • Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Held Target at $125 on, Wednesday, July 8th, 2020


This is the rating of the analyst that currently disagrees with Michelle


  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $113 on, Wednesday, August 19th, 2020